Canine Otitis Externa: Diagnosis & Management Registration
Sponsored by Elanco Animal Health
Respond to this quick survey and register to download your otitis externa diagnostic & management tree.
CAUTION: Federal (U.S.A.) law restricts these drugs to use by or on the order of a licensed veterinarian.
PRECAUTIONS: For use in dogs only. Do not use in cats (see POST APPROVAL EXPERIENCE). CLARO® has been associated with rupture of the tympanic membrane. Reevaluate the dog if hearing loss or signs of vestibular dysfunction are observed during treatment. Signs of internal ear disease such as head tilt, vestibular signs, ataxia, nystagmus, facial paralysis, and keratoconjunctivitis sicca have been reported (see POST APPROVAL EXPERIENCE) with the use of CLARO®. Claro Product Label
SUROLAN® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate) is indicated for the treatment of canine otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).
Important Safety Information: Do not use Surolan otic suspension in dogs with known perforated tympanum or with drugs known to induce ototoxicity. If overgrowth of non-susceptible bacteria or fungi occurs, treatment should be discontinued and appropriate therapy instituted. Long-term use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hypoadrenocorticism in dogs. The safe use of Surolan in breeding animals has not been evaluated. Please see product insert attached for full prescribing information. Surolan Product Label
PRECAUTIONS: The safe use of Baytril® Otic in dogs used for breeding purposes, during pregnancy, or in lactating bitches has not been evaluated. The use of Baytril® Otic in dogs with perforated tympanic membranes has not been evaluated. Therefore, the integrity of the tympanic membrane should be evaluated before administering this product. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use of Baytril® Otic. Baytril Otic Product Label
EASOTIC is a registered trademark of Virbac S.A.
Mometemax, Posatex and Otomax are registered trademarks of Intervet Inc., doing business as Merck Animal Health, a subsidiary of Merck & Co., Inc. All right reserved.
Osurnia is a registered trademark of Dechra Limited.
©2021 Elanco or its affiliates. Surolan, Claro, Baytril, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-21-1584